A noninvasive method for predicting clinically significant prostate cancer using magnetic resonance imaging combined with PRKY promoter methylation level: a machine learning study

Yufei Wang,Weifeng Liu,Zeyu Chen,Yachen Zang,Lijun Xu,Zheng Dai,Yibin Zhou,Jin Zhu
DOI: https://doi.org/10.1186/s12880-024-01236-1
IF: 2.7949
2024-03-12
BMC Medical Imaging
Abstract:Traditional process for clinically significant prostate cancer (csPCA) diagnosis relies on invasive biopsy and may bring pain and complications. Radiomic features of magnetic resonance imaging MRI and methylation of the PRKY promoter were found to be associated with prostate cancer.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?